Icelandic Salmon earnings dip due to biological setbacks, weaker market

Operational and financial performance in the period was impacted by biological challenges and a high-cost base from the 2023 generation.

Icelandic Salmon CEO Bjorn Hembre
Icelandic Salmon CEO Bjorn HembrePhoto: Anders Furuset
Published 21 August 2025, 08:16Updated 22 August 2025, 07:58
IcelandSalMarNorwayOslo Stock Exchangebacterial kidney disease (BKD)